According to studies (Chuang et al., 2022; Xie et al., 2022), patients with high FAK expression have a significantly shorter survival than those with lower FAK expression, making FAK a promising indicator for early diagnosis of cancer and for predicting the prognosis of patients. The gene discussed is PTK2; the disease is cancer.